Amedisys Revenue, Profits - AMED Annual Income Statement

Add to My Stocks
$56.87 $0.41 (0.73%) AMED stock closing price Feb 20, 2018 (Closing)

Stock analysis based on fundamentals means looking at financial statements in addition to the Amedisys stock price. An income statement is one of the three key financial statements furnished by a company, the other two being the balance sheet and the cashflow statement. Like any other income statement, the AMED income statement also itemizes revenue/sales, operating expenses, and profits/bottomline for a quarter or year and reflects a YOY revenue growth of 12.25% when compared to the same period in the past. The operating expenses as shown in the Amedisys profit and loss statement for 2016 total to $547.05M. This line item shows that the operating expenses has decreased compared with last year. Also check: Amedisys assets and Amedisys free cash flow.

View revenue and profit details for latest and last 10 financial years.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec201620152014201320122011201020092008
Amedisys Revenues or Net Sales
1.44B1.28B1.2B1.25B1.49B1.47B1.63B1.51B1.19B
Cost Of Goods Sold (COGS)833.05M725.91M691.06M717.99M841.14M782.34M820.46M724.46M562.63M
Amedisys Gross Profit
604.39M554.62M513.49M531.34M646.75M688.01M813.85M788.99M624.78M
Research & Development Expense---------
Selling General & Admin Expense527.38M543.75M458.03M639.95M556.93M540.31M585.76M529.93M447.27M
Income Before Depreciation Depletion Amortization77.01M10.87M55.46M-108.6M89.82M147.7M228.09M259.06M177.5M
Depreciation Depletion Amortization19.67M20.03M31.41M46.36M202.02M618.56M34.58M28.31M20.4M
Non Operating Income9.38M19.64M5.14M5.9M5.67M-1.27M3.31M-
Interest Expense5.16M10.78M8.21M4.41M12.16M8.82M9.2M11.67M16.62M
Amedisys Pretax Income
61.56M-0.3M20.97M-153.47M-118.69M-478.8M185.58M222.39M141.35M
Provision for Income Taxes23.93M2M7.67M-58.77M-21.39M-103.42M72.3M86.17M54.71M
MinorityInterest----1.59M-14.99M----0.04M
Investment Gains Losses---------
Other Income---------
Income Before Extraordinaries & Disc Operations37.63M-2.31M13.3M-94.7M-97.3M-375.37M113.27M136.22M86.68M
Extraordinary Items & Discontinued Operations---0.21M-3.07M-1.28M-6.96M---
Amedisys Profit/ Loss (Net Income)
37.26M-3.02M12.77M-96.17M-83.58M-382.46M112.58M135.83M86.68M
Average Shares used to compute Diluted EPS33.74M33.02M32.82M31.25M29.9M28.69M28.48M27.76M26.43M
Average Shares used to compute Basic EPS33.2M33.02M32.3M31.25M29.9M28.69M28.03M27.23M26.43M
Income Before Nonrecurring Items52.18M48.88M23.87M8.57M32.76M66.24M122.31M135.84M89.13M
Income from Nonrecurring Items-14.92M-51.9M-10.88M-101.67M-115.07M-441.74M-9.73M--2.45M
Amedisys Earnings Per Share Basic Net
1.12-0.090.39-3.08-2.79-13.334.024.993.28
Amedisys Earnings Per Share Diluted Net
1.1M-0.09M--3.08M-2.79M-13.33M3.95M4.89M3.22M
EPS Diluted Before Nonrecurring Items1.551.480.730.271.082.274.294.893.31
Preferred Dividends Acc Pd---------
Dividends Common---------
Dividend Per Share Common0.000.000.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

It is very helpful to read a report on Amedisys stock analysis. An investor must check the following items in an income statement:

  • Revenue: This is the inflow that is generated from the sale of goods or services and is $1.44B for this year of 2016. Our Amedisys revenue chart gives a clear visual representation of how the topline or sales growth has been. Investors often invest only in those companies where the revenue is growing at a steady rate.
  • Bottom line: The word bottom line comes because it is usually the last line of the income statement and refers to the actual profits after deducting all expenses from the revenues. AMED stock had a healthy bottom line growth.

The income statement is also called the profit and loss statement. Apart from the AMED income statement, one can check the Amedisys historical stock prices to check how the price has moved with time.

Amedisys Income Statement - Key Financial Ratios

PE Ratio (price earnings ratio)
45.5
PS Ratio (price sales ratio)
1.29
Operating Margin
6.1
Net Profit Margin
3.8
Dividend Yield
0%